AVALON HEALTHCARE SOLUTIONS - Key Persons
Job Titles:
- Board Member at the Columbia Chamber of Commerce
Andy Folsom joined BlueCross BlueShield of South Carolina (BCBSSC) in Columbia, SC in 2009. He currently serves as AVP, Strategic Investments and M&A, and also as President of Companion Capital Management, Inc., a wholly owned subsidiary of BCBSSC. Prior to this role, Andy worked in the Law Department at BCBSSC as AVP and Deputy General Counsel. Before joining BCBSSC, Andy worked as a corporate transactional attorney at Alston & Bird in Atlanta, GA. Andy holds a BA from Washington and Lee University and a JD from the University of South Carolina School of Law.
In addition to his role at BCBSSC, Andy currently serves as a Board member at the Columbia Chamber of Commerce (Executive Committee member), United Way of the Midlands, Salute from the Shore (Chairman), Sisters of Charity Foundation of South Carolina (Executive Committee member), and Riverbanks Zoo Society (Executive Committee member).
In his role as Chief Growth Officer at Avalon Healthcare Solutions, Barry Davis is responsible for growing the company's revenues and services through a national business development strategy.
Barry possesses 30 years of healthcare experience working with and servicing health plans. Prior to joining Avalon in 2017, he was Sr. Vice President of the Health Plan Segment at OptumRx, the Pharmacy Benefit Management division of UnitedHealth Group. In that capacity, Barry led a cross-functional team managing a multi-billion dollar business.
Barry is a former member of the executive team for Chicago's CatamaranRx. He also spent nearly 20 years in various sales, service, and operations roles at Medco Health Solutions (now part of Express Scripts).
Barry holds a BSBA from Bucknell University.
Job Titles:
- CHIEF EXECUTIVE OFFICER
- Member of the Board of Directors
- Member of the Executive Team
Good clinical decision-making requires ordering the right test at the right time from the right provider. With the science of laboratory testing exploding, Dr. Kerr is pleased to be a part of the Avalon team's ability to scale laboratory science into the healthcare ecosystem.
Before cofounding Avalon, Dr. Kerr was the Chief Medical and Growth Officer at CareCentrix, a company focused on health in the home. Prior to CareCentrix, Dr. Kerr was the Chief Medical Officer at WellCare Health Plans and Blue Cross Blue Shield of Florida. Dr. Kerr was previously Vice President of Professional Networks at Independence Blue Cross and regional medical director for a number of plans in Texas.
Dr. Kerr holds a BA from the University of Arkansas, an MBA from the University of Houston, an MD from the University of Arkansas. He was also a research associate in the Nuffield department of pathology at the University of Oxford.
Job Titles:
- Director
- Member of the Clinical Advisory Board
- Professor and Vice Chair
Dr. Rubin is Professor and Vice Chair of Pathology, Director, Soft Tissue Pathology, Director, Bone & Soft Tissue Pathology Fellowship Program, Staff, Department of Cancer Biology and Practicing Pathologist with sub-specialty expertise in bone and soft tissue tumors, Cleveland Clinic.
Dr. Rubin is Staff, Department of Cancer Biology, Lerner Research Institute and Cleveland Clinic.
Job Titles:
- Member of the Clinical Advisory Board
- Chairman of the Department of Laboratory Medicine
Dr. Smith is Chair of the Department of Laboratory Medicine at the Yale School of Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is also the Chief of Laboratory Medicine at Yale New Haven Hospital.
Dr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women's Hospital, Boston Children's Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. He practices in all of his subspecialty areas. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-coagulation interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His educational activities include direction of an NIH-funded research training program in Immunohematology and Transfusion Medicine. He also lectures in the areas of biomedical ethics, "therapeutic pathology", and in the education of the physician-scientist. Nationally, he has been member and chair for various NIH and American Heart Association research study sections, chair of the Association of Pathology Chairs Research Committee, and a member of the CDC Clinical Laboratory Integration into Healthcare Collaborative. He is the recipient of a number of Awards including Stohlman Scholar of the Leukemia & Lymphoma Society, National Blood Foundation Scholar, the Evans Award from the Academy of Clinical Laboratory Physicians and Scientists, and has served as a visiting professor at a number of universities.
Job Titles:
- Chairman and Director of the New York EHealth Collaborative
- Special Advisor to the CEO of the University of Rochester ( U of R ) Medical Center
David is a special advisor to the CEO of the University of Rochester (U of R) Medical Center, a professor of public health sciences in the U of R School of Medicine and Dentistry and an executive professor of health care management in the U of R William E. Simon Graduate School of Business (Simon School).
David was CEO of The Lifetime Healthcare Companies (TLHC) in Rochester, NY which includes Excellus BlueCross BlueShield, Univera Healthcare, Lifetime Health Medical Group, Lifetime Care, EBS-RMSCO Benefit Solutions and MedAmerica.
David serves as chair and director of the New York eHealth Collaborative overseeing the state's Health Information Technology initiatives.
Job Titles:
- Member of the Board of Directors
- Operating Partner Role With Francisco Partners
- Operating Partner With Francisco Partners
Duncan James is an Operating Partner with Francisco Partners and focuses on the healthcare IT market.
Prior to Operating Partner role with Francisco Partners, Duncan was the CEO of two private-equity backed healthcare IT companies, MModal and QuadraMed. He also served as Group President at McKesson Corporation for 9 years responsible for the hospital and health systems market solutions and was a member of the McKesson Corporate Operating Committee. Duncan brings more than 25 years of experience in healthcare IT spanning domestic and international operations, strategic planning, sales and marketing, services, and product management.
Duncan serves on the Board of additional Francisco Partner companies including e-Solutions, Nextech, and QGenda. He received his Bachelor of Science degree in Industrial Management from the Georgia Institute of Technology.
Job Titles:
- Member of the Board of Directors
- Partner at Francisco Partners
Ezra Perlman is a Partner at Francisco Partners and focuses primarily on investments in the software and services sectors, with a specific emphasis on healthcare technology.
Prior to joining Francisco Partners in 2003, Ezra was a venture capitalist with Battery Ventures, where he was involved in identifying, executing and managing private equity investments in software companies.
Ezra serves on the board of directors of Aesynt, API Healthcare, Healthland, Quantros, T-System and Therapeutic Research. He formerly served on the board of directors of Aconex, AdvancedMD, Attachmate, Attenti, Avangate, LYNX Medical Systems, RedPrairie, and SMART Modular.
Job Titles:
- Chairman of the Clinical Advisory Board
- Chairman of the Avalon Clinical Advisory Board
- Member of the Academy of Clinical Laboratory Physicians
Dr. Baird is the Chair of the Avalon Clinical Advisory Board. He is board-certified in Anatomic and Clinical Pathology as well as Clinical Chemistry. Dr. Baird serves as Professor and Chair of Laboratory Medicine and Pathology at the University of Washington in Seattle, WA. He is also the Director of Clinical Chemistry at Harborview Medical Center and Director of the UW Clinical Chemistry Fellowship Program.
Dr. Baird has served on numerous local and national committees, including the CMS/PAMA Clinical Diagnostic Laboratory Test Panel and ASCP's Choosing Wisely Campaign Committee, where he has been instrumental in developing the ASCP's Choosing Wisely recommendations. He is the recipient of the AACC's Grannis Award for Excellence in Research and Scientific Publication and the International Federation of Clinical Chemistry's Young Investigator award.
Dr. Baird is a member of the Academy of Clinical Laboratory Physicians and Scientists, the American Association for Clinical Chemistry, and the German Society of Clinical Chemistry and Laboratory Medicine. His clinical interests include rational laboratory test utilization, chemistry and toxicology, molecular diagnostics and proteomics.
Dr. Baird is a graduate of Stanford University, with a BS in Chemistry. He received his MD and PhD at the University of California, San Diego. He completed his residency in Anatomic and Clinical Pathology at the University of Washington in Seattle and a subspecialty fellowship training in molecular pathology and immunohistochemistry at PhenoPath Laboratories.
Holly Benson recently retired as the EVP, President and CEO of Health Care Enterprises which is a division of Centene Corporation and currently serves as a Board member and advisor for several companies. In her role at Centene, she led a portfolio of entrepreneurial acquisitions, including the country's largest in-home primary care provider (USMM), an 18-clinic primary care group (Community Medical Group), a multi-state third party administrator (HealthSmart), a provider of services to individuals with Intellectual and Developmental Disabilities (LifeShare), an industry-leading case management software company (Casenet) and a cutting-edge health care analytics company (Interpreta). She was responsible for helping grow those companies, expanding their product offerings to internal and external customers and integrating core functions into Centene.
Holly joined Centene in March 2011 as Centene's Senior Vice President of Health Policy. In that role, she was responsible for the development of policy positions for the company and worked with health plan and specialty company presidents to develop Centene's policy agenda. She also worked with the business development team to craft policy solutions in new markets.
Before joining Centene, Holly served as Secretary for the Florida Agency for Health Care Administration, the state agency responsible for Florida's Medicaid program. She also served as Secretary for the Florida Department of Business and Professional Regulation, and she served as a member of the Florida House of Representatives. During her time in the House, Ms. Benson served as Chair of the Health Care Council, of the Select Committee on Article V, and of the Committee on State Administration. Ms. Benson also spent 10 years practicing municipal bond law with Miller, Canfield, Paddock and Stone, P.L.C.
Ms. Benson graduated with honors from Dartmouth College and earned her law degree from the University of Florida College of Law. She serves on the Board of Ascension Florida and served on the Boards of the St. Louis Sports Commission, the Missouri History Museum, and LaunchCode. She also served on the Selection Committee for Arch Grants and was the founder of St. Louis Opera Theatre's Intermezzo Society.
Job Titles:
- Member of the Clinical Advisory Board
- Professor of Pathology and Chair, Department of Clinical Sciences
Dr. Gibson is Professor of Pathology and Chair, Department of Clinical Sciences and the Associate Dean for Faculty Affairs at the University of Central Florida College of Medicine. She teaches in the M.D. program, and practices at Nemours Children's Health Orlando and Delaware.
Dr. Gibson is board certified by the American Board of Medical Genetics and Genomics (ABMGG), is a Founding Fellow of the American College of Medical Genetics (ACMG), and serves as a member of the American Board of Medical Genetics and Genomics Board of Directors, and the Association for Molecular Pathology Board of Directors. She served as a member of the Molecular Genetic Pathology Fellowship Milestones taskforce for the Accreditation Council for Graduate Medical Education (ACGME), and is a current member of the Test Development Committee for the American Board of Pathology. Dr. Gibson received her training at the University of Florida College of Medicine, and her practice includes molecular pathology and molecular genetics. She has served as the Director of Molecular Genetics for Orlando Health-M.D. Anderson Cancer Center Orlando, and later as the Director of Molecular Genetics and Cytogenetics for AmeriPath, Inc. (A Division of Quest Diagnostics).
Dr. Gibson is a graduate of the prestigious Hedwig van Amerigen Executive Leadership in Academic Medicine (ELAM) fellowship program. She is active in a number of national-level professional societies including the American College of Medical Genetics, the Association for Professors of Human and Medical Genetics, the Association for Molecular Pathology, and the Association of Pathology Chairs. She serves on editorial boards for the Journal of Molecular Diagnostics, and the Med Ed Portal Faculty Affairs Collection (AAMC). She has authored a number of book chapters, articles, and published abstracts in the fields of molecular pathology and genetics, and has been the principle investigator for numerous clinical trials.
Job Titles:
- EXECUTIVE VICE PRESIDENT of PRODUCT
Dr. Jason Bush is Executive Vice President, Product at Avalon Healthcare Solutions, where he is responsible for product strategy, design, and management.
Jason has more than 20 years of experience in leadership positions in venture capital-backed healthcare and life sciences companies. He joined Avalon in 2015 as the Senior Vice President of Clinical Operations and business owner for Avalon's proprietary, best-in-class, flagship software, which automates the application of laboratory policies to health insurance claims. He was promoted to Chief Data Officer leading data analytics, advanced analytics, underwriting, business model analysis, and reporting services. Prior to that, Jason served as Vice President of Operations at AIT Laboratories (now HealthTrackRX), a commercial toxicology and forensic science laboratory, where he was integral in the company's restructuring. As former Director of Clinical Operations for Precision Therapeutics (now Helomics, a Predictive Oncology Company), Jason led the laboratory through two years of 300 percent growth.
Jason received his Ph.D. in Chemical Engineering - Bioengineering from Carnegie Mellon University and an MBA from the University of Pittsburgh.
As a Partner at Echo Health Ventures in Boston, Jessica A. Zeaske, PhD, MHS, MBA, identifies and invests in emerging and growth stage companies for Echo. She is a seasoned venture capitalist and board leader having worked at independent, corporate, and university funds, and has written dozens of investment themes over the years. She previously served as Director of Healthcare Investments at GE Ventures where she invested in precision health companies. Jessica came to GE Ventures from Lemhi Ventures, a fund investing in healthcare services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech and Life Science companies based on University intellectual property at U of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up healthcare delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven healthcare start-up companies.
Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica currently serves on the Boards of Avalon Healthcare Services, Genome Medical and Wildflower Health and is a Board Observer at Abacus Insights. Her previous Board of Director experience includes Apervita, Arcadia.io, PlanSource, OneHealth, PokitDok, Orasi Medical, Medication Management Solutions, plus significant work at Bind On-Demand Health Insurance. Jessica also serves on the Board of DentaQuest Partnership for Oral Health Advancement, is a Trustee for Boston Medical Center's Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children's Hospital, and is a member of the National Association of Corporate Directors.
As Chief Financial Officer of Avalon Healthcare Solutions, John Adams is responsible for the company's day to day financial and accounting functions. He plays a strategic role in the company's overall management, including shaping payor contracts, customer pricing strategies, broader business model decisions, and future M&A opportunities.
Prior to joining Avalon in December of 2018, John served as CFO of California-based Medicare Advantage plan Alignment Healthcare, as well as of clinical laboratory services company Accumen. His other leadership roles have included EVP & COO at marketing services company Acxiom; EVP of Business Solutions at healthcare software company Eclipsys; and CFO of AT&T Business Services. John's experience ranges from global, multi-billion-dollar businesses to start-up and young high-growth companies backed by private equity investors. Early in his career, John worked with EDS in various financial and operational roles for 15 years.
John has a BA in economics from the University of Exeter (UK). He is a member of the Institute of Chartered Accountants.
Job Titles:
- CHIEF CLIENT OFFICER
- Healthcare Solutions' Chief Client Officer
Kerri Fritsch is Avalon Healthcare Solutions' Chief Client Officer. She leads the Client Management department with a focus on exceeding client expectations and enhancing client value. Kerri has also fostered effective relationships with Avalon's client base and values collaborative partnerships.
Prior to joining Avalon in 2015, Kerri held leadership positions in client management, operations, and financial management. She was VP of Client Services at New Century Health and VP of Product Development at CareCentrix, where she helped develop and launch a successful hospital readmission reduction program. Kerri's other health plan roles have included VP of Finance for WellCare's health services division and AVP of Performance Management for AmeriGroup FL.
Kerri also served as CEO of physician practice management company CoreManagement, which specialized in billing and operational solutions for primary care and specialty practices.
Kerri holds a BS in Finance from Providence College, where she was a division I scholarship athlete for tennis. She received her MBA/MHA from Pfeiffer University.
Job Titles:
- Member of the Board of Directors
- Vice President Network Business Development and Retail Solutions at Health Care Service Corporation
Lauren Macklis is Vice President Network Business Development and Retail Solutions at Health Care Service Corporation (HCSC). HCSC is the largest customer owned-health insurer in the United States, operating Blue Cross Blue Shield Illinois, Montana, New Mexico, Oklahoma and Texas. Lauren oversees Value Based Care Payment Operations, Provider Partnerships, Provider Payment Innovation and Analytics, as well as Retail Solutions (Individual U65).
Prior to her current role, Lauren was Vice President Divisional Strategy and Analytics, where Lauren developed line of business strategy and investment portfolio for Government and Consumer Solutions, and led the Government Programs Business Execution teams, as well as the Individual Markets data and analytics team.
Before joining HCSC in 2011, Lauren led strategic planning and business development teams at Rush University Medical Center, a large academic medical center and health sciences university. While at Rush, Lauren implemented several initiatives for the medical center including multi-hospital telemedicine network, off-site clinics, and practice affiliations.
Lauren received a Master of Health Services Administration from the University of Michigan and a Bachelor's degree in Community Health - Health Planning and Administration from the University of Illinois.
Lynn Metter is Chief Technology Officer (CTO) at Avalon Healthcare Solutions and is responsible for the company's technology strategy roadmap, partnering with Avalon's product teams to deliver features and releases required for product development.
Lynn is a passionate software delivery executive with more than 25 years of experience building and leading agile teams that design and support complex software solutions. Since 2002, he has focused exclusively on technology that improves healthcare efficiency and delivery. Prior to joining Avalon, Lynn was CTO at DataLink Software, where he led the organization through significant platform improvements on the company's value-based care solution for large payers and Management Services Organizations (MSOs). Lynn previously served as the Chief Delivery Officer of Ingenious Med and spent 16 years at Change Healthcare (formerly McKesson Corporation).
Lynn holds a BS in Computer Science from Columbus State University and an MBA from the University of Phoenix.
Michele Norton has over 25 years' experience in healthcare across many facets of the industry including payer, provider, ACO's and life sciences organizations. She brings considerable experience and expertise in healthcare technology product, go to market strategy and marketing as well as optimization of clinical and analytics solutions and tech enabled services. Michele's role includes defining the value and positioning, developing go to market strategies, and collaborating to create a strategic commercialization plan at scale for the Avalon portfolio of solutions. She is responsible for the full spectrum of marketing strategy and operations.
Prior to joining Avalon, Michele was the Chief Product and Strategy Officer at MobileSmith Health which focused on mobile care technology for patients across PeriOp services and previous Chief Marketing and Product Officer at HealthMyne which focused on novel AI-enabled radiomic solutions for RWD and Life Sciences markets. In addition, she has held various senior executive positions at SCIO Health Analytics an EXL company, Zynx Health part of the Hearst Health family and McKesson Corporation. Her clinical and nursing informatics background provides her with a unique perspective on the impact data and technology can have on care quality and outcomes. She is passionate about helping clients translate insights into action, improve processes, drive engagement, measure outcomes and disseminate results.
Michele received her Bachelor of Science in Nursing with high honors from the University of Florida and her Master of Science in Nursing with a healthcare informatics specialty from the University of Colorado Health Sciences Center. She has lectured and published nationally and internationally and is a member of several industry organizations.
Job Titles:
- EXECUTIVE VICE PRESIDENT of PROVIDER NETWORKS
As Executive Vice President of Provider Networks for Avalon Healthcare Solutions, Mike Snyder manages laboratory networks that support high-quality, cost-effective laboratory services while promoting appropriate testing for patients.
Mike has more than 30 years of experience in the development of clinical laboratory strategies. Prior to joining Avalon, he was the Principal for Clinical Lab Business Solutions, a consulting firm that engages with laboratories to deliver collaborative solutions to health plans and employer groups. Mike has also served as Vice President of Laboratory Networks for UnitedHealthcare (UHC). In that capacity, he directed the company's national strategy for laboratory services and participated in the development of its national provider network.
Previously, Mike served as Director of Business Development for Mount Sinai Hospital's Center for Clinical Laboratories, where he saw outreach revenues triple following the implementation of a business plan that focused efforts on billing solutions and demonstrated the value of the medical center's laboratory to attending faculty. Finally, Mike served as an executive with LabCorp (1980-2000), one of the largest commercial laboratories in the US.
He received his undergraduate degree at East Carolina University before commencing post-graduate studies at the University of North Carolina.
Job Titles:
- Member of the Executive Team
- PRESIDENT
As President of Avalon Healthcare Solutions, Pamela is responsible for providing strategic leadership and advancing the company's mission and vision, while maximizing revenue, profitability, and growth of the organization.
Pamela has extensive healthcare experience from the world's largest health insurers and pharmaceutical companies to VC backed and early-stage start up organizations. Prior to joining Avalon, Pamela served as President and Global Chief Commercial Officer of Sidekick Health, an innovative, Iceland-based digital therapeutics platform company. She was responsible for developing the US market entry strategy, delivering top line revenue and profitability, and leading the enterprise marketing team responsible for international patient acquisition and partnership strategies with major pharmaceutical companies.
Before joining Sidekick, Pamela served as President and CEO of Anthem Blue Cross and Blue Shield of Georgia where she was responsible for their 3rd largest commercial health plan with $2.7B in revenue and 1.3M members. She also enjoyed an 11-year career at UnitedHealth Group where she held a number of positions including CEO of its Wisconsin Medicaid business, Senior Vice President of Consumer Strategy, Senior Vice President of Sales Operations and Organizational Effectiveness, and Senior Vice President of Marketing.
Pamela began her career at Merck & Co. as a hospital sales representative and quickly advanced into broader commercial leadership roles. She was asked to join the founding team that built and established Astra Merck and served in various leadership roles throughout the company evolution to AstraZeneca. She also served as an officer of Orphan Medical where she led the launch of their flagship product, Xyrem, and was a key executive in the sale of the company to Jazz Pharmaceuticals. She also established commercial strategies and teams at a privately held pioneering telemedicine company, American Telecare, and a spinal cord injury device company, InVivo Therapeutics.
Pamela has a B.S. from St. Olaf College. In addition, she currently sits on the following boards, the Emory Center for Ethics, the Woodruff Arts Foundation, and the Atlanta Midtown Alliance.
In her role as Avalon Healthcare Solutions' Chief Operating Officer, Shantha Diaz leads the Information Technology, Claims & Clinical Operations, Policy Development, Quality, Clinical Configuration, Client Implementation, and Corporate Development activities.
Prior to joining Avalon in 2017, Shantha was Chief Operating Officer of Neighborhood Health Plan of Rhode Island. In that capacity, she helped implement ACA, launched three new product lines, doubled the plan's membership, and contributed to increasing the company's revenue to $1.1 Billion dollars.
Shantha previously served as Staff VP of Medical Business Solutions at Anthem Blue Cross Blue Shield. She also spent several years in information technology roles at Humana, International Data Group, and Toyota.
Shantha holds a BS in Finance and Accounting from the University of Bombay and a PG in Computer Applications from India's National Institute of Information Technology.
Job Titles:
- Member of the Board of Directors
- Chief Marketing & Engagement Officer
Stephany Verstraete serves as the Chief Marketing & Engagement Officer at Teladoc Health Inc., responsible for all marketing, communications and consumer visit revenue for the global leader in whole person virtual care.
A seasoned, high-growth leader who has held executive marketing roles spanning a breadth of industries in both public and private companies, Stephany has a proven record of building businesses and leading during periods of outstanding growth.
With a 20+ year record of successfully building brands and growing high-performing teams, she has held leadership roles at Match.com, Expedia, Hostess and PepsiCo. She was also a member of the founding team at a travel-based start-up.
Proficient in Spanish & French, Stephany holds an International Master of Business Administration from York University and an Honors Bachelor of Economics from Queen's University in Canada.
Steve Morgan is General Counsel at Avalon Healthcare Solutions. An attorney with extensive healthcare regulatory, transactional, and management experience, Steve is responsible for all legal, compliance, and government affairs matters pertaining to the company.
Prior to joining Avalon in 2015, Steve spent a decade with the nation's largest pharmacy benefit manager, Express Scripts. Serving as Vice President and Associate General Counsel, Steve managed a team of attorneys and compliance officers supporting numerous Express Scripts businesses, including its PBM, government programs, Accredo Specialty Pharmacy, United BioSource Corporation, Freedom Fertility Pharmacy, and CuraScript SD Specialty Distribution. During Steve's tenure at Express Scripts, the company grew from $16 billion to more than $100 billion in annual revenue. This growth was fueled in part by numerous acquisitions for which Steve provided legal support, including Express Scripts' $29 billion acquisition of Medco Health Solutions.
Steve previously worked for two Washington, D.C. law firms, where his legal practice focused on managed care organizations, healthcare providers, and pharmaceutical manufacturers.
Steve received his BA with magna cum laude honors and a professional MBA from the University of Missouri. He received his JD with magna cum laude honors and MHA with distinction from St. Louis University.
Job Titles:
- Member of the Clinical Advisory Board
Dr. Timothy Hamill is the Prior Director of Clinical Laboratories at UCSF Medical Center's China Basin and Parnassus campuses. In addition, he is Professor Emeritus and Ex-Vice Chair of the UCSF Department of Laboratory Medicine.
Dr. Hamill has held numerous memberships in UCSF Medical Center committees in his tenure, including the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also past chair of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC). He is currently President and member of the Board for the California Society of Pathologists, and a fellow of the American Society of Clinical Pathologists and College of American Pathologists.
In his career, Dr. Hamill has taken a lead in promoting laboratory science as a career and clinical laboratory scientist training as the Co-Chair of the Hospital Laboratory Workforce Initiative of the California Hospital Association. In addition, he has also been involved in developing better point-of-care testing practices through the College of American Pathologists as the Vice-Chair of the Point of Care Testing Resource Committee.
Dr. Hamill completed his medical degree from UC Davis' School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in Hematopathology at the Veterans Administration Medical Center in Martinez, CA. He is board-certified in clinical pathology and also hematopathology.
Dr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.
In addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC's GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the Institute of Medicine/National Academy of Medicine's Roundtable on Translating Genomic-Based Research for Health and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC).
Dr. Pratt is Past Chair of the Clinical Practice Committee and is currently a member of the Professional Relations committee, and is the chair of the Program committee for the Association of Molecular Pathology. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association's (AMA's) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.
Dr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.
Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.
Job Titles:
- VICE PRESIDENT of HUMAN RESOURCES
- VP of Human Resources
Wendy Mudra is Vice President of Human Resources at Avalon Healthcare Solutions. In addition to being responsible for all tactical HR requirements at the company, she also plays a strategic role in staffing, organizational development, and creating a vibrant organizational culture.
Prior to joining Avalon in 2015 as its first Human Resources employee, Wendy had 20 years of experience in the HR field, primarily with small to midsize companies. She was the Director of Human Resources at start-up specialty property and casualty insurance company Mount Beacon Insurance Company. She also held management positions at HCI and IFCO Systems. Early in her career, Wendy obtained generalist experience at Airem Capital and Uniroyal Optoelectronics.
Wendy holds a BA in Political Science from Wittenberg University. She is also PHR-certified through the Society for Human Resources Management.